| 25.97 Delayed Data As of Sep 17 |  +0.60 / +2.36%Today’s Change | 16.00 Today|||52-Week Range 36.15 | +41.84% Year-to-Date |
| Previous close | 25.37 |
| Today’s open | 25.34 |
| Day’s range | 24.66 - 26.48 |
| Volume | 269,601 |
| Average volume (3 months) | 210,624 |
| Market cap | $708.5M |
| Earnings growth (last year) | +82.73% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +64.52% |
| P/E ratio | NM |
| Price/Sales | 10.70 |
| Price/Book | 14.15 |
| Today’s change | Today’s % change | |
|---|---|---|
| VCELVericel Corp | -0.10 | -0.62% |
| PETQPetIQ Inc | -1.48 | -5.47% |
| KPTIKaryopharm Therapeut... | -0.18 | -1.52% |
| VNDAVanda Pharmaceutical... | -0.02 | -0.15% |
| Next reporting date | October 31, 2019 |
| EPS forecast (this quarter) | -$0.46 |
| Annual revenue (last year) | $37.6M |
| Annual profit (last year) | -$31.5M |
| Net profit margin | -83.80% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer E. Kevin Hrusovsky |
Vice President-Operations, Service & Quality Bruce J. Bal |
Corporate headquarters Billerica, Massachusetts |
